ATE539766T1 - Intranasale influenzaimpfstoffe aus virosomen - Google Patents

Intranasale influenzaimpfstoffe aus virosomen

Info

Publication number
ATE539766T1
ATE539766T1 AT09178084T AT09178084T ATE539766T1 AT E539766 T1 ATE539766 T1 AT E539766T1 AT 09178084 T AT09178084 T AT 09178084T AT 09178084 T AT09178084 T AT 09178084T AT E539766 T1 ATE539766 T1 AT E539766T1
Authority
AT
Austria
Prior art keywords
influency
virosomes
vaccines
intranasal
intranasal influency
Prior art date
Application number
AT09178084T
Other languages
English (en)
Inventor
Alexander J Kersten
Lisya Gerez
Pieter J Schoen
Jozef J P Nauta
Rheineck Leyssius Dorine Van
Original Assignee
Abbott Biologicals Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Biologicals Bv filed Critical Abbott Biologicals Bv
Application granted granted Critical
Publication of ATE539766T1 publication Critical patent/ATE539766T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT09178084T 2006-03-22 2007-03-21 Intranasale influenzaimpfstoffe aus virosomen ATE539766T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78446206P 2006-03-22 2006-03-22
EP06111534 2006-03-22

Publications (1)

Publication Number Publication Date
ATE539766T1 true ATE539766T1 (de) 2012-01-15

Family

ID=38038698

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07727166T ATE451931T1 (de) 2006-03-22 2007-03-21 Intranasale influenza-vakzine auf basis von virosomen
AT09178084T ATE539766T1 (de) 2006-03-22 2007-03-21 Intranasale influenzaimpfstoffe aus virosomen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT07727166T ATE451931T1 (de) 2006-03-22 2007-03-21 Intranasale influenza-vakzine auf basis von virosomen

Country Status (21)

Country Link
EP (2) EP1996229B1 (de)
JP (1) JP5285595B2 (de)
KR (1) KR20090016659A (de)
AR (1) AR059972A1 (de)
AT (2) ATE451931T1 (de)
AU (1) AU2007228736B2 (de)
BR (1) BRPI0709864A2 (de)
CA (1) CA2646895A1 (de)
DE (1) DE602007003815D1 (de)
DK (2) DK1996229T3 (de)
EA (1) EA014532B1 (de)
ES (2) ES2375436T3 (de)
HR (2) HRP20100144T1 (de)
IL (1) IL193840A (de)
MY (1) MY142996A (de)
NO (1) NO20084452L (de)
PL (2) PL2158921T3 (de)
PT (2) PT1996229E (de)
SA (1) SA07280116B1 (de)
SI (2) SI1996229T1 (de)
WO (1) WO2007107585A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110150926A1 (en) * 2008-08-01 2011-06-23 Mohammed Alsharifi Influenza vaccines
AP2013006835A0 (en) * 2010-11-02 2013-04-30 Zepeda Lopez Hector Manuel Novel vaccines against the A/H1N1 pandemic flu virus
US11523988B2 (en) 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018690D0 (en) * 1990-08-24 1990-10-10 Wellcome Found Vaccines
EP1447080A1 (de) * 2003-02-13 2004-08-18 Bestewil Holding B.V. Methode zur Herstellung von Virosomen-artigen Partikeln
AR056245A1 (es) * 2003-06-19 2007-10-03 Bestewil Holding Bv Membranas virales reconstituidas funcionales que contienen un coadyuvante

Also Published As

Publication number Publication date
MY142996A (en) 2011-02-14
ES2338382T3 (es) 2010-05-06
EP1996229A1 (de) 2008-12-03
IL193840A0 (en) 2011-08-01
PL1996229T3 (pl) 2010-05-31
DK1996229T3 (da) 2010-05-03
EP2158921B1 (de) 2012-01-04
BRPI0709864A2 (pt) 2011-07-26
EA014532B1 (ru) 2010-12-30
HRP20100144T1 (hr) 2010-04-30
CA2646895A1 (en) 2007-09-27
JP5285595B2 (ja) 2013-09-11
KR20090016659A (ko) 2009-02-17
SI1996229T1 (sl) 2010-04-30
EP2158921A1 (de) 2010-03-03
EA200870361A1 (ru) 2009-02-27
HRP20120013T1 (hr) 2012-01-31
EP1996229B1 (de) 2009-12-16
AU2007228736B2 (en) 2011-12-15
ES2375436T3 (es) 2012-02-29
SI2158921T1 (sl) 2012-03-30
PL2158921T3 (pl) 2012-06-29
DE602007003815D1 (en) 2010-01-28
ATE451931T1 (de) 2010-01-15
IL193840A (en) 2011-10-31
DK2158921T3 (da) 2012-05-07
WO2007107585A1 (en) 2007-09-27
NO20084452L (no) 2008-10-22
PT2158921E (pt) 2012-03-27
AR059972A1 (es) 2008-05-14
SA07280116B1 (ar) 2010-10-19
PT1996229E (pt) 2010-03-16
AU2007228736A1 (en) 2007-09-27
ES2375436T8 (es) 2012-03-15
JP2009530351A (ja) 2009-08-27

Similar Documents

Publication Publication Date Title
ATE450271T1 (de) Impfstoff
DE602006019782D1 (de) Kapselperforationsmodul
DE502007001629D1 (de) Rfahren
DE502007002453D1 (de) Kunstoffverdichtergehäuse
DK2214640T3 (da) Intranasale sammensætninger
EP2049032A4 (de) Verbesserter impinger
DE502007001652D1 (de) Notöltank
DE502007005975D1 (de) Wischblatt
DE602006016174D1 (de) Blisterverpackungsverfahren
BRPI0719956A2 (pt) Radiofluoração
ATE539766T1 (de) Intranasale influenzaimpfstoffe aus virosomen
FI20065260A0 (fi) Vaihdemodulaattori
DE502007001094D1 (de) Hubkupplung
DE602007010028D1 (de) En
SE0600253L (sv) Hållaranordning
FI20060398A0 (fi) Pellettipuristin
DE112007001450A5 (de) Verbessertes Surfrigg
ES1062366Y (es) Interruptor-seccionador aereo
SE0601081L (sv) Hållaranordning
ES1063205Y (es) Sabana encimera
ITFI20060258A1 (it) Vibro paradonto
ITMN20060046A1 (it) Aereo
UA14346S (uk) Скульптура
ES1062293Y (es) Cubitera
FI7640U1 (fi) Jätesäkinpidike